MIJ invests in DiscGenics
MIJ invests in Gene Therapy Research Institution Co., Ltd.
MIJ invests in CellGenTech, Inc.
MIJ invests in EdiGENE Corporation (now Modalis Therapeutics Corporation)
MIJ enters into a capital agreement with SanBio Co, Ltd.
Establishment of a consortium providing one-stop support for the processes following healthcare start-ups’ clinical development
MIJ Launches a New Biotech Fund in Partnership with Nippon Shinyaku and Torii Pharmaceutical. Promoting the discovery and nurturing of innovative start-ups in the field of bioscience in Japan and overseas, focusing on the UK.
Medical Incubator Japan K.K. (MIJ) to establish a capital and business agreement with SanBio Co, Ltd. MIJ will support acceleration of proper use/distribution of regenerative cell medicine SB623.